LIM
GSK icon

Lagoda Investment Management’s GSK GSK Stock Holding History

Lagoda Investment Management’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-139
Closed -$8K – 41
2016
Q3 		$8K Hold
139
– – ﹤0.01% 29
2016
Q2 		$8K Hold
139
– – ﹤0.01% 28
2016
Q1 		$7K Sell
139
-52
-27% -$2.59K ﹤0.01% 30
2015
Q4 		$10K Hold
191
– – ﹤0.01% 33
2015
Q3 		$9K Sell
191
-24
-11% -$1.25K ﹤0.01% 32
2015
Q2 		$11K Sell
215
-40
-16% -$2.25K ﹤0.01% 30
2015
Q1 		$15K Sell
255
-145
-36% -$8.31K ﹤0.01% 32
2014
Q4 		$21K Buy
+400
New +$22.4K 0.01% 43

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Lagoda Investment Management's GSK Position: Q4 2016 in Review

Lagoda Investment Management sold out of GSK (GSK) in Q4 2016, closing a stake of 139 shares — an estimated $8K sold.

Lagoda Investment Management first reported a position in GSK in Q4 2014 and held it in 8 quarters. The position peaked at $21K in Q4 2014. 762 funds tracked by Wall St. Rank hold GSK as of Q4 2016.

  • Lagoda Investment Management reported no remaining GSK position as of Q4 2016 after selling out during the quarter.
  • Lagoda Investment Management sold 139 GSK shares in Q4 2016, an estimated $8K.
  • Lagoda Investment Management first reported a position in GSK in Q4 2014 and held it in 8 quarters.
  • Lagoda Investment Management's GSK position peaked at $21K in Q4 2014.
  • 762 funds tracked by Wall St. Rank held GSK as of Q4 2016.

Based on Lagoda Investment Management's 13F filing for Q4 2016, filed 24 Jan 2017.